The characteristics of Korean elderly multiple myeloma patients aged 80 years or over
Even in patients with MM aged 80 years or over, chemotherapy can result in better survival outcomes than supportive care. Patients aged ≥ 80 years should not be excluded from chemotherapy based on age alone. However, reducing EM in elderly patients with newly diagnosed MM remains challenging.
Authors
- Joonho Moon (ORCID: https://orcid.org/0000-0001-6513-557X)
- Young Rok (ORCID: https://orcid.org/0000-0003-1631-1359)
- Mi Hwa Heo (ORCID: https://orcid.org/0000-0003-3997-8463)
- Sung Hwa Bae (ORCID: https://orcid.org/0000-0002-5279-6341)
- Hee Jeong Cho (ORCID: https://orcid.org/0000-0001-8300-8179)
- Jiyoon Jung (ORCID: https://orcid.org/0000-0002-5560-9468)
- Yu‐Yan Hwang (ORCID: https://orcid.org/0000-0002-8207-2248)
- Min Kyoung Kim (ORCID: https://orcid.org/0000-0003-0291-8512)
- Sang Hwan Lee (ORCID: https://orcid.org/0000-0001-5782-4551)
Institutions
- Kyungpook National University Hospital (KR)
- Daegu Fatima Hospital (KR)
- Daegu Catholic University Medical Center (KR)
- Keimyung University Dongsan Medical Center (KR)
- Yeungnam University Medical Center (KR)
- Keimyung University (KR)
Publication Details
- Journal
- The Korean Journal of Internal Medicine
- Published
- 2024-12-31
- DOI
- https://doi.org/10.3904/kjim.2024.041
- Citations
- 1
- Primary Topic
- Multiple Myeloma Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.45